DK1310517T3 - Mælkesyrepolymer og fremgangsmåde til fremstilling af denne - Google Patents

Mælkesyrepolymer og fremgangsmåde til fremstilling af denne

Info

Publication number
DK1310517T3
DK1310517T3 DK01954447T DK01954447T DK1310517T3 DK 1310517 T3 DK1310517 T3 DK 1310517T3 DK 01954447 T DK01954447 T DK 01954447T DK 01954447 T DK01954447 T DK 01954447T DK 1310517 T3 DK1310517 T3 DK 1310517T3
Authority
DK
Denmark
Prior art keywords
weight
preparation
lactic acid
acid polymer
sustained
Prior art date
Application number
DK01954447T
Other languages
English (en)
Other versions
DK1310517T4 (da
Inventor
Yoshio Hata
Kohei Yamamoto
Tsutomu Tani
Takashi Aoki
Original Assignee
Wako Pure Chem Ind Ltd
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18729814&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1310517(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wako Pure Chem Ind Ltd, Takeda Pharmaceutical filed Critical Wako Pure Chem Ind Ltd
Publication of DK1310517T3 publication Critical patent/DK1310517T3/da
Application granted granted Critical
Publication of DK1310517T4 publication Critical patent/DK1310517T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/88—Post-polymerisation treatment
    • C08G63/89—Recovery of the polymer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
    • C08G63/08—Lactones or lactides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/88—Post-polymerisation treatment
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/91—Polymers modified by chemical after-treatment
    • C08G63/912—Polymers modified by chemical after-treatment derived from hydroxycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK01954447.7T 2000-08-07 2001-08-06 Mælkesyrepolymer og fremgangsmåde til fremstilling af denne DK1310517T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000238051 2000-08-07
PCT/JP2001/006721 WO2002012369A1 (en) 2000-08-07 2001-08-06 Lactic acid polymer and process for producing the same

Publications (2)

Publication Number Publication Date
DK1310517T3 true DK1310517T3 (da) 2006-07-24
DK1310517T4 DK1310517T4 (da) 2011-01-17

Family

ID=18729814

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01954447.7T DK1310517T4 (da) 2000-08-07 2001-08-06 Mælkesyrepolymer og fremgangsmåde til fremstilling af denne

Country Status (14)

Country Link
US (3) US7019106B2 (da)
EP (2) EP1310517B2 (da)
JP (2) JP5046447B2 (da)
KR (1) KR100772950B1 (da)
CN (1) CN1269870C (da)
AT (1) ATE322513T1 (da)
AU (1) AU2001276733A1 (da)
CA (1) CA2419065C (da)
CY (1) CY1117889T1 (da)
DE (1) DE60118575T3 (da)
DK (1) DK1310517T4 (da)
ES (2) ES2256276T5 (da)
PT (2) PT1310517E (da)
WO (1) WO2002012369A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7019106B2 (en) * 2000-08-07 2006-03-28 Wako Pure Chemical Industries, Ltd. Lactic acid polymer and process for producing the same
TWI332407B (en) 2001-06-29 2010-11-01 Takeda Chemical Industries Ltd Controlled release composition and method of producting the same
US20060183205A1 (en) * 2003-01-29 2006-08-17 Laurent Masaro Method for controlling molecular weight and distribution of biopolymers
JP4205497B2 (ja) * 2003-06-23 2009-01-07 帝人株式会社 リン脂質を含有するポリ乳酸樹脂組成物および成形体
EP1666518B1 (en) * 2003-09-08 2018-03-28 Chugai Seiyaku Kabushiki Kaisha Hyaluronic acid modification products and drug carriers using them
MXPA06012241A (es) * 2004-04-23 2007-03-07 Amgen Inc Polimeros de acido polilactico de bajo peso molecular.
WO2005114322A2 (en) * 2004-05-12 2005-12-01 Massachusetts Institute Of Technology Manufacturing process, such as three-dimensional printing, including solvent vapor filming and the like
TW200613012A (en) * 2004-07-02 2006-05-01 Takeda Pharmaceuticals Co Sustained-release composition, process for producing the same and use of the same
ATE382337T1 (de) * 2005-04-28 2008-01-15 Nipro Corp Bioabsorbierbare pharmazeutische zusammensetzung enthaltend einen plga-copolymer
AU2007207618B2 (en) 2006-01-18 2011-03-24 Foresee Pharmaceuticals Co., Ltd. Pharmaceutical compositions with enhanced stability
US8076448B2 (en) 2006-10-11 2011-12-13 Tolmar Therapeutics, Inc. Preparation of biodegradable polyesters with low-burst properties by supercritical fluid extraction
NL2000454C1 (nl) * 2006-11-28 2008-01-02 Purac Biochem Bv Stabiele lactidedeeltjes.
US20080146822A1 (en) 2006-11-28 2008-06-19 Purac Biochem B.V. Stable lactide particles
CA2670931C (en) * 2006-11-28 2016-01-12 Purac Biochem Bv Stable lactide particles
JP4564098B2 (ja) 2006-12-18 2010-10-20 武田薬品工業株式会社 徐放性組成物およびその製造法
DK3660073T3 (da) * 2007-02-15 2023-09-18 Tolmar International Ltd Poly(lactid-co-glycolid) med lav sprængning
JP5229917B2 (ja) * 2007-05-16 2013-07-03 独立行政法人産業技術総合研究所 乳酸オリゴマーおよびその製造方法
US9486531B2 (en) 2008-06-03 2016-11-08 Indivior Uk Limited Dehydrated hydrogel inclusion complex of a bioactive agent with flowable drug delivery system
AU2009255675B2 (en) 2008-06-03 2014-10-09 Tolmar Therapeutics, Inc. Controlled release copolymer formulation with improved release kinetics
BR112012032544A2 (pt) * 2010-06-25 2016-10-11 Takeda Pharmaceutical formulação de liberação prolongada, uso de um composto, e, método para produzir a formulação de liberação prolongada.
US8834694B2 (en) * 2010-12-27 2014-09-16 Mo Bio Laboratories, Inc. Dry compositions and methods for gel electrophoresis
JP5959728B2 (ja) * 2013-04-11 2016-08-02 三井化学株式会社 乳酸―グリコール酸共重合体の製造法またはその塩の製造法
EA201692083A1 (ru) 2014-04-16 2017-03-31 Вейкс-Фарма Гмбх Фармацевтическая композиция для ветеринарии и ее применение
EP4374861A3 (en) 2015-11-16 2024-08-07 MedinCell S.A. A method for morselizing and/or targeting pharmaceutically active principles to synovial tissue
SG11202001688WA (en) * 2017-08-31 2020-03-30 Evonik Corp Improved resorbable polymer purification process
BR112023005807A2 (pt) 2020-09-30 2023-05-02 Tolmar International Ltd Sistema de liberação de polímero biodegradável para liberação prolongada de testosterona
WO2024168022A2 (en) 2023-02-10 2024-08-15 Tolmar, Inc. Degarelix polymeric formulations
WO2025008759A1 (en) 2023-07-05 2025-01-09 Tolmar International Limited Polymeric leuprolide acetate formulations

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3297033A (en) * 1963-10-31 1967-01-10 American Cyanamid Co Surgical sutures
US3565869A (en) * 1968-12-23 1971-02-23 American Cyanamid Co Extrudable and stretchable polyglycolic acid and process for preparing same
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US3755558A (en) * 1971-02-23 1973-08-28 Du Pont Polylactide drug mixtures for topical application atelet aggregation
US3839297A (en) * 1971-11-22 1974-10-01 Ethicon Inc Use of stannous octoate catalyst in the manufacture of l(-)lactide-glycolide copolymer sutures
US3912692A (en) * 1973-05-03 1975-10-14 American Cyanamid Co Process for polymerizing a substantially pure glycolide composition
US3890283A (en) * 1973-06-04 1975-06-17 American Cyanamid Co Process for post-polymerizing polyglycolic acid
US4249531A (en) * 1979-07-05 1981-02-10 Alza Corporation Bioerodible system for delivering drug manufactured from poly(carboxylic acid)
US4273920A (en) * 1979-09-12 1981-06-16 Eli Lilly And Company Polymerization process and product
PH19942A (en) 1980-11-18 1986-08-14 Sintex Inc Microencapsulation of water soluble polypeptides
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
FR2507115A1 (fr) * 1981-06-04 1982-12-10 Atelier Rectification Affutage Outil de percage comprenant au moins trois goujures
NL8200101A (nl) * 1982-01-13 1983-08-01 Philips Nv Scheerapparaat.
US4479911A (en) * 1982-01-28 1984-10-30 Sandoz, Inc. Process for preparation of microspheres and modification of release rate of core material
US4605730A (en) * 1982-10-01 1986-08-12 Ethicon, Inc. Surgical articles of copolymers of glycolide and ε-caprolactone and methods of producing the same
US4539981A (en) * 1982-11-08 1985-09-10 Johnson & Johnson Products, Inc. Absorbable bone fixation device
FR2537980B1 (fr) * 1982-12-17 1986-12-19 Sandoz Sa Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation
CH656884A5 (de) * 1983-08-26 1986-07-31 Sandoz Ag Polyolester, deren herstellung und verwendung.
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
CA1256638A (en) * 1984-07-06 1989-06-27 Motoaki Tanaka Polymer and its production
JP2551756B2 (ja) * 1985-05-07 1996-11-06 武田薬品工業株式会社 ポリオキシカルボン酸エステルおよびその製造法
GB8609537D0 (en) * 1986-04-18 1986-05-21 Ici Plc Polyesters
EP0452111B1 (en) * 1990-04-13 1998-07-15 Takeda Chemical Industries, Ltd. Biodegradable high-molecular polymers, production and use thereof
JP3200706B2 (ja) * 1990-04-13 2001-08-20 武田薬品工業株式会社 生体内分解型高分子重合物
JP3065384B2 (ja) * 1991-06-05 2000-07-17 旭硝子株式会社 ラクチド系重合体の製造方法
TW333456B (en) * 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
JP3490171B2 (ja) 1994-02-21 2004-01-26 武田薬品工業株式会社 生体内分解性ポリマーの末端カルボキシル基におけるエステル
US5594091A (en) 1994-02-21 1997-01-14 Takeda Chemical Industries, Ltd. Matrix for sustained-release preparation
US5763513A (en) * 1994-05-19 1998-06-09 Mitsui Toatsu Chemicals, Inc. L-lactic acid polymer composition, molded product and film
JP3520609B2 (ja) * 1995-06-26 2004-04-19 東洋紡績株式会社 脂肪族ポリエステルの製造方法
JP3086851B2 (ja) * 1997-02-12 2000-09-11 西川ゴム工業株式会社 ポリヒドロキシカルボン酸樹脂の製造方法
US6264970B1 (en) * 1996-06-26 2001-07-24 Takeda Chemical Industries, Ltd. Sustained-release preparation
ES2221019T3 (es) * 1996-10-31 2004-12-16 Takeda Chemical Industries, Ltd. Preparacion de liberacion mantenida.
JPH1135670A (ja) * 1997-07-23 1999-02-09 Mitsui Chem Inc ポリヒドロキシカルボン酸の単離方法
CA2316273A1 (en) 1998-01-16 1999-07-22 Takeda Chemical Industries, Ltd. Sustained-release composition, method of its production and use thereof
JPH11269094A (ja) 1998-01-16 1999-10-05 Takeda Chem Ind Ltd 徐放性組成物、その製造法および用途
US6114495A (en) * 1998-04-01 2000-09-05 Cargill Incorporated Lactic acid residue containing polymer composition and product having improved stability, and method for preparation and use thereof
US6565874B1 (en) * 1998-10-28 2003-05-20 Atrix Laboratories Polymeric delivery formulations of leuprolide with improved efficacy
PT1158014E (pt) † 1998-12-15 2005-04-29 Takeda Pharmaceutical Processo para a producao de poliesteres biodegradaveis
JP3716146B2 (ja) * 1998-12-15 2005-11-16 武田薬品工業株式会社 ポリマーの製造方法
JP2000238051A (ja) 1999-02-23 2000-09-05 Kansei Corp 表皮シートの発泡成形型へのセッティング方法
MXPA02000461A (es) 1999-07-15 2002-07-30 Takeda Chemical Industries Ltd Composiciones de liberacion prolongada, metodos para producir las mismas y uso de estas.
US7019106B2 (en) 2000-08-07 2006-03-28 Wako Pure Chemical Industries, Ltd. Lactic acid polymer and process for producing the same
US6362308B1 (en) * 2000-08-10 2002-03-26 Alkermes Controlled Therapeutics Inc. Ii Acid end group poly(d,l-lactide-co-glycolide) copolymers high glycolide content

Also Published As

Publication number Publication date
EP1693054B1 (en) 2016-05-25
CA2419065A1 (en) 2002-02-14
ES2256276T5 (es) 2011-02-22
JP5622760B2 (ja) 2014-11-12
ES2256276T3 (es) 2006-07-16
EP1310517B2 (en) 2010-11-17
ATE322513T1 (de) 2006-04-15
PT1693054T (pt) 2016-07-07
CY1117889T1 (el) 2017-05-17
DE60118575D1 (de) 2006-05-18
US20030153724A1 (en) 2003-08-14
KR100772950B1 (ko) 2007-11-02
CN1269870C (zh) 2006-08-16
EP1693054A3 (en) 2007-07-11
US7019106B2 (en) 2006-03-28
PT1310517E (pt) 2006-05-31
AU2001276733A1 (en) 2002-02-18
US20070259036A1 (en) 2007-11-08
WO2002012369A9 (en) 2003-04-24
WO2002012369A1 (en) 2002-02-14
DE60118575T3 (de) 2011-05-19
JP2002121272A (ja) 2002-04-23
EP1310517B1 (en) 2006-04-05
US8092830B2 (en) 2012-01-10
JP2012107256A (ja) 2012-06-07
CN1461321A (zh) 2003-12-10
US20060128938A1 (en) 2006-06-15
DE60118575T2 (de) 2006-08-24
DK1310517T4 (da) 2011-01-17
ES2577389T3 (es) 2016-07-14
KR20030046405A (ko) 2003-06-12
HK1095526A1 (en) 2007-05-11
CA2419065C (en) 2009-12-22
EP1310517A1 (en) 2003-05-14
EP1310517A4 (en) 2005-01-05
JP5046447B2 (ja) 2012-10-10
EP1693054A2 (en) 2006-08-23

Similar Documents

Publication Publication Date Title
DK1310517T4 (da) Mælkesyrepolymer og fremgangsmåde til fremstilling af denne
ATE272394T1 (de) Zubereitung mit verzögerter freisetzung
ATE220898T1 (de) Nifedipinzubereitung mit langanhaltender freisetzung
ATE109000T1 (de) System zur freisetzung von medikamenten und dessen herstellungsmethode.
EA200000584A2 (ru) Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием
DE69930240D1 (de) Matrizes gebildet aus polymer und hydrophoben verbindungen zur verwendung bei der freisetzung von arzneimitteln
ATE324872T1 (de) Orale pharmazeutische zusammensetzung mit verzögerter wirkstofffreigabe von protonenpumpen- hemmern
DE69721489D1 (de) Herstellungsverfahren von löslichen verabreichungssystemen unter verwendung von flüchtigen salzen
DK0560092T3 (da) Tabletter, granulater og pellets med højt indholdaf aktivstoffer til højkoncentrerede, faste administreringsformer
DK0761213T3 (da) Fremgangsmåde til fremstilling af præparat med forlænget frigivelse
NO20020084D0 (no) Preparater med vedvarende frigivelse, fremgangsmåter for fremstille disse og anvendelser av disse
CA2158630A1 (en) Dosage forms containing thioctic acid or solid salts of thioctic acid with improved release and bioavailability
MY142066A (en) Controlled release composition comprising lactic acid polymer, and method of producing the same
DE60232147D1 (de) Pharmazeutische zubereitung mit verzögerter wirkstoff-freisetzung enthaltend milchsäure-glycolsäure copolymer, und verfahren zu deren herstellung
MY148370A (en) Sustained-release composition and method for producing the same
NO970990D0 (no) Implanterbare formlegemer for administrering av virkestoffer til planter
SE9704401D0 (sv) Matrix pellets for greasy, oily or sticky drug substances
ATE309788T1 (de) Mikropartikel mit verbessertem freisetzungsprofil und verfahren zu deren herstellung
GR3018795T3 (en) Emulsion-free emulsion polymers in sustained-release pharmaceutical compositions and their production
CA2532714A1 (en) Oral sustained-release tablet comprising 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide
RU2002124643A (ru) Биологически активная добавка "витаминка цветочная"